Inactive Instrument
Hydropothecary Corp Share Price Toronto S.E.
Stocks
THCX
CA44903W1059
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - CAD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 21/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 14/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 03/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 29/08/2021 |
William Montour
BRD | Director/Board Member | - | 04/01/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.78% | -3.60% | +104.55% | -2.25% | 2.44B | ||
| -0.12% | -4.22% | +68.81% | +112.41% | 1.61B | ||
| 0.00% | -0.65% | -36.57% | +168.63% | 449M | ||
| -1.75% | -3.45% | +16.67% | +40.00% | 60.71M | ||
| Average | -1.20% | -2.89% | +38.36% | +79.69% | 1.14B | |
| Weighted average by Cap. | -1.63% | -2.55% | +76.86% | +55.63% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HEXO Stock
- THCX Stock
Select your edition
All financial news and data tailored to specific country editions
















